Specific IgG4 Production during House Dust Mite Immunotherapy among Age, Gender and Allergic Disease Populations

International Archives of Allergy and Immunology

Volumn 160, Issue 1, 2012, Pages 37-46

  Lai, Xuxin ^a   Li, Jing ^b   Xiao, Xiaoxiong ^c   Liu, Enmei ^d   Zhang, Chunqing ^b   Wang, Hongyu ^b   Gjesing, Birgitte ^a   Zhong, Nanshan ^b   Spangfort, Michael D ^a  

^a ALK A/S   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Zhongshan bo'Ai Hospital Affiliated to Southern Medical University   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Allergen specific immunoglobulin G4; Allergen specific immunotherapy; House dust mite

Indexed keywords

ALUTARD; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SUBCUTANEOUS IMMUNOTHERAPY; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; ASTHMA; CHILD; CHILD, PRESCHOOL; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; YOUNG ADULT;

EID: 84865576642     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000339239     Document Type: Article

References (20)

1. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: Therapeutic vaccines for allergic diseases: A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
2. Wang H, Lin X, Hao C, Zhang C, Sun B, Zheng J, Chen P, Sheng J, Wu A, Zhong N: A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy 2006; 61: 191-197. (Pubitemid 43381829)
3. Larché M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761-771. (Pubitemid 44453462)
4. Jutel M, Akdis CA: Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011; 66: 725-732.
5. Akkoc T, Akdis M, Akdis CA: Update in the mechanisms of allergen-specific immunotherapy. Allergy Asthma Immunol Res 2011; 3: 11-20.
6. Aalberse RC, Stapel SO, Schuurman J, Rispers T: Immunoglobulin G4: An odd antibody. Clin Exp Allergy 2009; 39: 469-477.
7. Van Neerven RJ, Knol EF, Ejrnaes A, Würtzen PA: IgE-mediated allergen presentation and blocking antibodies: Regulation of T cell activation in allergy. Int Arch Allergy Immunol 2006; 141: 119-129. (Pubitemid 44413287)
8. Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip JP, Arock M: Inhibition of IgE-induced activation of human mast cell by IL-10. Clin Exp Allergy 2001; 31: 694-704. (Pubitemid 32823813)
9. James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, Jacobson MR, Kimber I, Till SJ, Durham SR: Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011; 127: 509-516.
10. Li J, Sun B, Huang Y, Lin X, Zhao D, Tan G, Wu J, Zhao H, Cao L, Zhong N: China Alliance of Research on Respiratory Allergic Disease: A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy 2009; 64: 1083-1092.
11. Zhang C, Gjesing B, Spangfort MD, Xu J, Zhong N: The allergen-specific IgE reactivity pattern of Chinese house dust mite allergic patients. Allergy 2008; 63: 1640-1641.
12. Zheng YW, Li J, Lai XX, Zhao DY, Liu XF, Lin XP, Gjesing B, Palazzo P, Mari A, Zhong NS, Spangfort MD: Allergen micro-array detection of specific IgE reactivity in Chinese allergic patients. Chin Med J 2011; 124: 4350-4354.
13. Xiao X, Wang D, Cui B, Lai X, Gjesing B, Spangfort M, Zhong N: The effect on Der f specific IgG4 of mite allergic patient after Der p specific immunotherapy (in Chinese). Chin J Allergy Clin Immunol 2009; 3: 34-38.
14. Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM: Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002; 129: 1-18. (Pubitemid 35316844)
15. Rossi RE, Monasterolo G: Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 3, 7, 11, 12 and nPhl p 4)-specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Int Arch Allergy Immunol 2004; 135: 44-53. (Pubitemid 39279431)
16. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O: Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116: 608-613. (Pubitemid 41267135)
17. Van Metre TE Jr, Adkinson NF Jr, Lichtenstein LM, Mardiney MR Jr, Norman PS Jr, Rosenberg GL, Sobotka AK, Valentine MD: A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol 1980; 65: 288-297. (Pubitemid 10084862)
18. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ: Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121: 1120-1125.
19. Hales BJ, Martin AC, Pearce LJ, Laing IA, Hayden CM, Goldblatt J, Le Souëf PN, Thomas WR: IgE and IgG anti-house dust mite specificities in allergic disease. J Allergy Clin Immunol 2006; 118: 361-367. (Pubitemid 44142702)
20. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Möller C; PAT Investigator Group: Five-year follow-up on the PAT study: Specific immunotherapy and longterm prevention of asthma in children. Allergy 2006; 61: 855-859. (Pubitemid 43893987)